CLOV
Clover Health Investments, Corp. NASDAQ Listed Jun 12, 2020$2.68
After hrs
$2.63
-1.87%
Mkt Cap $1.4B
52w Low $1.58
47.0% of range
52w High $3.92
50d MA $2.09
200d MA $2.53
P/E (TTM)
-15.9x
EV/EBITDA
-13.6x
P/B
4.5x
Debt/Equity
0.0x
ROE
-26.5%
P/FCF
-17.6x
RSI (14)
—
ATR (14)
—
Beta
2.25
50d MA
$2.09
200d MA
$2.53
Avg Volume
6.0M
About
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is base…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | -0.10 | -0.05 | +51.0% | 2.15 | -4.2% | -2.8% | -5.1% | -7.0% | +0.5% | -3.7% | — |
| Nov 4, 2025 | AMC | 0.02 | -0.05 | -350.0% | 3.52 | -19.9% | -15.6% | -25.9% | -24.1% | -26.1% | -27.6% | — |
| Aug 5, 2025 | AMC | 0.03 | 0.03 | +0.0% | 2.85 | -18.2% | -20.7% | -22.5% | -23.5% | -13.3% | -12.3% | — |
| May 6, 2025 | AMC | -0.07 | 0.05 | +171.4% | 3.35 | +3.0% | +12.5% | +11.9% | +4.8% | +3.6% | +1.5% | — |
| Mar 11, 2025 | AMC | -0.07 | -0.04 | +42.9% | 3.36 | +3.9% | +7.4% | +3.0% | +8.9% | +10.1% | +13.4% | — |
| Nov 6, 2024 | AMC | -0.01 | -0.02 | -50.3% | 4.35 | -10.6% | -15.6% | -21.6% | -23.4% | -25.3% | -27.4% | — |
| Aug 5, 2024 | AMC | -0.05 | 0.01 | +120.0% | 1.88 | +6.4% | -2.7% | -11.2% | -2.7% | -1.1% | -0.5% | — |
| May 7, 2024 | AMC | -0.07 | -0.05 | +28.6% | 0.74 | +19.5% | +17.6% | +16.7% | +10.8% | +23.2% | +37.8% | — |
| Mar 12, 2024 | AMC | -0.18 | -0.12 | +33.3% | 0.77 | +10.7% | +5.0% | -5.5% | +3.9% | +2.0% | +7.0% | — |
| Nov 6, 2023 | AMC | -0.10 | -0.09 | +10.0% | 1.13 | -15.3% | -18.2% | -20.2% | -21.9% | -20.1% | -20.4% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $1.89 | $1.91 | +1.1% | +0.0% | -2.1% | -3.7% | -3.7% | -4.8% |
| Mar 5 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $2.16 | $2.16 | +0.0% | -4.2% | -7.4% | -7.4% | -7.9% | -6.5% |
| Jan 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.54 | $2.50 | -1.6% | +2.0% | +3.1% | +5.5% | +2.0% | -2.0% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.97 | $2.99 | +0.7% | -12.1% | -10.1% | -12.5% | -14.1% | -15.5% |
| Aug 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.26 | $2.29 | +1.3% | -2.2% | -3.5% | +9.3% | +10.6% | +15.9% |
| Aug 6 | UBS | Maintains | Neutral → Neutral | — | $2.85 | $2.33 | -18.2% | -20.7% | -22.5% | -23.5% | -13.3% | -12.3% |
| Mar 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $3.97 | $3.96 | -0.3% | -8.3% | -6.3% | -3.5% | -7.6% | -8.3% |
| Aug 11 | Citigroup | Maintains | Neutral → Neutral | — | $1.32 | $1.30 | -1.5% | +13.6% | +18.2% | +7.6% | +6.8% | +3.8% |
| Mar 6 | Credit Suisse | Maintains | Underperform → Underperform | — | $1.09 | $1.08 | -0.9% | -11.0% | -6.4% | -10.1% | -12.3% | -16.1% |
| Mar 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $1.09 | $1.08 | -0.9% | -11.0% | -6.4% | -10.1% | -12.3% | -16.1% |
Recent Filings
8-K · 2.02
!! High
Clover Health Investments, Corp. -- 8-K 2.02: Earnings Results
Clover Health reported first-quarter 2026 financial results on May 6, with investors now able to assess the company's operational performance and financial health during that period.
May 6
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Clover Health's executive leadership transition on March 30, 2026 signals potential strategic shifts in company direction, requiring investors to monitor whether replacement leadership can improve operational performance and profitability.
Apr 1
8-K · 7.01
! Medium
Clover Health Investments, Corp -- 8-K 7.01: Regulation FD Disclosure
Clover Health (CLOV) disclosed supplemental Q&A responses via Form 8-K, providing investors updated company information available on its investor relations website.
Mar 6
8-K · 7.01
! Medium
Clover Health Investments, Corp -- 8-K 7.01: Regulation FD Disclosure
Clover Health disclosed supplemental Q&A responses via 8-K filing, providing investors additional transparency on company operations and strategy through publicly available investor relations materials.
Mar 6
8-K
Clover Health Investments, Corp -- 8-K Filing
Clover Health Investments (CLOV) filed its required 8-K report on February 26, 2026, maintaining SEC compliance and transparency with investors regarding material corporate developments.
Feb 26
Data updated apr 25, 2026 1:44am
· Source: massive.com